Contemporary Reviews in Interventional Cardiology Interventional Cardiology Perspective of Functional Tricuspid Regurgitation

نویسندگان

  • Shikhar Agarwal
  • Rene Rodriguez
  • Carmela D. Tan
  • Samir R. Kapadia
چکیده

A vast unmet need exists for tricuspid valve (TV) repair for functional tricuspid regurgitation (FTR) among patients undergoing left heart valve surgery. The FTR is a dynamic entity that is governed by several pathophysiologic mechanisms like TV annular dilatation, annular shape, pulmonary hypertension, left or right ventricle dysfunction, right ventricle geometry, and leaflet tethering. Treatment options for FTR are primarily surgical. No clear medical management exists for treatment of FTR. Several studies have demonstrated improvement in functional status along with tricuspid regurgitation grades among individuals undergoing concomitant TV repair as compared with those undergoing only left heart valve surgery, although data on mortality benefits are equivocal. Percutaneous TV technology may be initially useful for patients with FTR who are at high risk for open-heart surgery. Once the other percutaneous technologies for mitral, aortic, or pulmonary valve become widely available, the need for percutaneous TV procedures will be even more apparent. Initial data from animal studies have shown encouraging results. A concurrent effort is being invested to develop effective mechanistic models, right stent materials, superior valve devices along with a precise technology for valve deployment. The current prevalence of moderate-to-severe tricuspid regurgitation (TR) is estimated to be 1.6 million in the United States.1 Of these, only 8000 patients undergo tricuspid valve (TV) surgeries annually, most of them in conjunction with left heart valve surgeries (LHVSs).1 This has resulted in a vast unmet need of recognizing and effectively treating TR in adult populations. With the decline of rheumatic heart disease, a large proportion of the TR encountered is functional rather than organic. Functional TR (FTR) refers to the TR secondary to the left heart pathology or right heart pathology in the face of a normal TV leaflet morphology.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Transcatheter interventions for tricuspid regurgitation - heterotopic technology: TricValve.

Introduction Considering the incidence of tricuspid regurgitation (TR) and its implications on functional status and long-term survival, TR is currently undertreated. With the increasing adoption of catheterbased treatments of other types of structural heart disease there is a growing interest and need for effective interventional treatment also for tricuspid regurgitation. Therefore, multiple ...

متن کامل

Percutaneous treatment of tricuspid regurgitation: A new therapeutic horizon.

Functional tricuspid regurgitation is a prevalent disease, especially among patients with other valve disorders, and is associated with significant morbidity and mortality. Its management is challenging, and many patients deemed at high surgical risk are managed conservatively. Despite optimization of pharmacological treatment, many patients continue to be symptomatic, thus leading to interest ...

متن کامل

Transapical transcatheter aortic valve implantation followed by transfemoral transcatheter edge-to-edge repair of the tricuspid valve using the MitraClip system – a new treatment concept for an inoperable patient with significant aortic stenosis and severe tricuspid valve regurgitation

Corresponding author: Marek Kowalski MD, PhD, Cardiology Department, Schuechtermann-Klinik, Ulmenallee 5-11, 49214 Bad Rothenfelde, Germany, phone: +49 542464130023, e-mail: [email protected] Received: 3.05.2016, accepted: 11.06.2016. Transapical transcatheter aortic valve implantation followed by transfemoral transcatheter edge-to-edge repair of the tricuspid valve using the M...

متن کامل

Percutaneous Therapy for Tricuspid Regurgitation: A New Frontier for Interventional Cardiology.

In the editorial by Kapadia et al, “Percutaneous Therapy for Tricuspid Regurgitation: A New Frontier for Interventional Cardiology,” which published online ahead of print March 23, 2017 (Circulation. 2017;135 [e-pub ahead of print]. DOI: 10.1161/ CIRCULATIONAHA.116.026533), a correction is needed. The following statement was made in error: “This patient population is obviously very sick and suf...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2010